DHPYX
Price
$17.11
Change
+$0.14 (+0.82%)
Updated
Jun 6 closing price
Net Assets
126.85M
VMVAX
Price
$84.21
Change
+$0.61 (+0.73%)
Updated
Jun 6 closing price
Net Assets
29.95B
Interact to see
Advertisement

DHPYX vs VMVAX

Header iconDHPYX vs VMVAX Comparison
Open Charts DHPYX vs VMVAXBanner chart's image
Diamond Hill Mid Cap Y
Price$17.11
Change+$0.14 (+0.82%)
VolumeN/A
Net Assets126.85M
Vanguard Mid-Cap Value Index Admiral
Price$84.21
Change+$0.61 (+0.73%)
VolumeN/A
Net Assets29.95B
DHPYX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHPYX vs. VMVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHPYX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 29.9B vs. DHPYX (127M). VMVAX pays higher dividends than DHPYX: VMVAX (2.31) vs DHPYX (1.25). DHPYX was incepted earlier than VMVAX: DHPYX (11 years) vs VMVAX (14 years). DHPYX (0.65) is less costly to investors than VMVAX (0.07). DHPYX (19.00) and VMVAX (19.00) have comparable annual turnover. VMVAX has a lower initial minimum investment than DHPYX: VMVAX (3000) vs DHPYX (500000). VMVAX annual gain was more profitable for investors over the last year : 6.48 vs. DHPYX (-0.18). VMVAX return over 5 years is better than : 56.36 vs. DHPYX (45.19).
DHPYXVMVAXDHPYX / VMVAX
Total Expense Ratio0.650.07929%
Annual Report Gross Expense Ratio0.650.07929%
Fund Existence11 years14 years-
Gain YTD1.678-0.166-1,011%
Front LoadN/AN/A-
Min. Initial Investment500000300016,667%
Min. Initial Investment IRAN/AN/A-
Net Assets127M29.9B0%
Annual Yield % from dividends1.252.3154%
Returns for 1 year-0.186.48-3%
Returns for 3 years-0.4711.23-4%
Returns for 5 years45.1956.3680%
Returns for 10 years63.3779.7979%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SBIO31.580.57
+1.84%
ALPS Medical Breakthroughs ETF
FDL42.090.44
+1.06%
First Trust Morningstar Div Leaders ETF
CHI10.230.07
+0.69%
Calamos Convertible Opportunities and Income Fund
GLO5.310.01
+0.19%
Clough Global Opportunities Fund
SNPG45.84N/A
N/A
Xtrackers S&P 500 Growth Scrd & Scrn ETF